FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC
Jun 17, 2026
View online
FDA Approves Belzutifan Plus Pembrolizumab for Adjuvant RCC
Jérôme Salomon and Lutz Dommel: Cancer Becomes a Global Strategic Priority in Historic G7 Declaration
VCCC Alliance Congratulates Robert Thomas on Recognition in the 2026 King’s Birthday Honours
EMBER-3 PRO Analysis Supports Quality-of-Life Profile of Imlunestrant in Advanced ER-Positive/HER2-Negative Breast Cancer
Neeraj Agarwal: AHA and ASCO Joint Statement on Defining Cardiovascular Endpoints in Oncology Trials
LAGOON Trial: 3 Critical Results From Zepzelca in Second-Line SCLC
Delta Goodrem Inspiring Cancer Journey: Hodgkin Lymphoma, Recovery, and Eurovision Return
Global Ovarian Cancer Research Consortium AI Accelerator Grant — OCRA
ACOG Foundation 2026 Request for Grant Proposals
ESMO Advanced Course on Management of Diffuse Large B-Cell Lymphoma (DLBCL) 2026: Singapore
Multidisciplinary Masterclass in Oncology: Summer edition – European School of Oncology
The Voice of Oncology
Unsubscribe
|
Manage subscription
OncoDaily, P53 Inc.
867 Boylston Street, 5th Floor, Suite 1094, Boston, MA 02116
Copyright (C) 2023-2026. OncoDaily, P53 Inc. All rights reserved.
